Literature DB >> 17885240

Assessment of vasculature of meningiomas and the effects of embolization with intra-arterial MR perfusion imaging: a feasibility study.

A J Martin1, S Cha, R T Higashida, S P Cullen, V Halbach, C F Dowd, M W McDermott, D A Saloner.   

Abstract

BACKGROUND AND
PURPOSE: Embolization of meningiomas has emerged as a preoperative adjuvant therapy that has proved effective in mitigating blood loss during surgical resection. Arterial supply to these tumors is typically identified by diffuse areas of parenchymal staining after selective x-ray angiograms. We investigate the benefits that selective injection of MR contrast may have in identifying vascular territories and determining the effects of embolization therapy.
MATERIALS AND METHODS: Selective intra-arterial (IA) injection of dilute MR contrast media was used to assess the vascular distribution territories of meningeal tumors before and after embolization therapy. Regions of the tumor that experienced loss of signal intensity after localized contrast injections into the external and common carotid as well as vertebral arteries were used to quantify the specific vessel's volume of distribution. Assessments were made before and after embolization to reveal changes in the vascular supply of the tumor. MR findings were compared with radiographic evaluation of tumor vascular supply on the basis of conventional x-ray angiography.
RESULTS: MR proved to be an excellent means to assess tissue fed by selected arteries and clearly demonstrated the treated and untreated portions of the neoplasm after therapy. In some instances, MR revealed postembolization residual enhancement of the tumor that was difficult to appreciate on x-ray angiograms. Very low contrast dose was necessary, which made repeated assessment during therapy practical.
CONCLUSION: MR perfusion imaging with selective IA injection of dilute contrast can reveal the distribution territory of vessels. Changes in tumor vasculature could be detected after embolization, which reveal the volumetric fraction of the tumor affected by the therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885240      PMCID: PMC8134219          DOI: 10.3174/ajnr.A0647

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

1.  On the heating of linear conductive structures as guide wires and catheters in interventional MRI.

Authors:  W R Nitz; A Oppelt; W Renz; C Manke; M Lenhart; J Link
Journal:  J Magn Reson Imaging       Date:  2001-01       Impact factor: 4.813

2.  Preoperative embolization for meningeal tumors: evaluation of vascular supply with angio-CT.

Authors:  Toshinori Hirai; Yukunori Korogi; Ken Ono; Shozaburo Uemura; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

3.  Pulsed star labeling of arterial regions (PULSAR): a robust regional perfusion technique for high field imaging.

Authors:  Xavier Golay; Esben T Petersen; Francis Hui
Journal:  Magn Reson Med       Date:  2005-01       Impact factor: 4.668

4.  Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects.

Authors:  A Villringer; B R Rosen; J W Belliveau; J L Ackerman; R B Lauffer; R B Buxton; Y S Chao; V J Wedeen; T J Brady
Journal:  Magn Reson Med       Date:  1988-02       Impact factor: 4.668

Review 5.  Progress in the diagnosis and treatment of patients with meningiomas. Part I: diagnostic imaging, preoperative embolization.

Authors:  H H Engelhard
Journal:  Surg Neurol       Date:  2001-02

6.  Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity.

Authors:  Janine M Lupo; Soonmee Cha; Susan M Chang; Sarah J Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

7.  Preoperative intracranial meningioma embolization: technical considerations affecting the risk-to-benefit ratio.

Authors:  R E Latchaw
Journal:  AJNR Am J Neuroradiol       Date:  1993 May-Jun       Impact factor: 3.825

8.  Delayed surgical resection reduces intraoperative blood loss for embolized meningiomas.

Authors:  Jay Y Chun; Michael W McDermott; Kathleen R Lamborn; Charles B Wilson; Randall Higashida; Mitchel S Berger
Journal:  Neurosurgery       Date:  2002-06       Impact factor: 4.654

9.  Preoperative embolization of intracranial meningiomas with Embosphere microspheres.

Authors:  S O Rodiek; A Stölzle; Ch B Lumenta
Journal:  Minim Invasive Neurosurg       Date:  2004-10

10.  Preoperative embolization of meningiomas.

Authors:  G B Hieshima; F R Everhart; C M Mehringer; F Tsai; A H Hasso; V S Grinnell; H F Pribram; M Mok
Journal:  Surg Neurol       Date:  1980-08
View more
  14 in total

1.  Arterial spin-labeling is useful for the diagnosis of residual or recurrent meningiomas.

Authors:  Kazufumi Kikuchi; Akio Hiwatashi; Osamu Togao; Koji Yamashita; Ryotaro Kamei; Koji Yoshimoto; Koji Iihara; Satoshi O Suzuki; Toru Iwaki; Yuriko Suzuki; Hiroshi Honda
Journal:  Eur Radiol       Date:  2018-04-13       Impact factor: 5.315

2.  Evaluation of the applicability of territorial arterial spin labeling in meningiomas for presurgical assessments compared with 3-dimensional time-of-flight magnetic resonance angiography.

Authors:  Yiping Lu; Shihai Luan; Li Liu; Ji Xiong; Jianbo Wen; Jianxun Qu; Daoying Geng; Bo Yin
Journal:  Eur Radiol       Date:  2017-03-16       Impact factor: 5.315

Review 3.  Advanced Imaging of Intracranial Meningiomas.

Authors:  Benita Tamrazi; Mark S Shiroishi; Chia-Shang J Liu
Journal:  Neurosurg Clin N Am       Date:  2016-02-18       Impact factor: 2.509

4.  Post-embolisation susceptibility changes in giant meningiomas: multiparametric histogram analysis using non-contrast-enhanced susceptibility-weighted PRESTO, diffusion-weighted and perfusion-weighted imaging.

Authors:  Tomokazu Nishiguchi; Takeshi Iwakiri; Kohji Hayasaki; Masahiko Ohsawa; Tetuya Yoneda; Yutaka Mitsuhashi; Akimasa Nishio; Vincent Dousset; Yukio Miki
Journal:  Eur Radiol       Date:  2012-09-26       Impact factor: 5.315

5.  Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls.

Authors:  Joseph L Wiemels; Margaret Wrensch; Jennette D Sison; Mi Zhou; Melissa Bondy; Lisa Calvocoressi; Peter M Black; Herbert Yu; Joellen M Schildkraut; Elizabeth B Claus
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

Review 6.  Contemporary endovascular embolotherapy for meningioma.

Authors:  Gregory J Dubel; Sun Ho Ahn; Gregory M Soares
Journal:  Semin Intervent Radiol       Date:  2013-09       Impact factor: 1.513

7.  Is sagittal sinus resection in falcine meningiomas a factor of bad surgical outcome?

Authors:  Paulo Henrique Pires de Aguiar; Rogério Aires; Marcos Vinicius Calfatt Maldaun; Adriana Tahara; Antonio Marcos de Souza Filho; Carlos Alexandre Zicarelli; Ricardo Ramina
Journal:  Surg Neurol Int       Date:  2010-10-25

8.  Assessment of vascular supply of hypervascular extra-axial brain tumors with 3T MR regional perfusion imaging.

Authors:  A Sasao; T Hirai; S Nishimura; H Fukuoka; R Murakami; M Kitajima; T Okuda; M Akter; M Morioka; S Yano; H Nakamura; K Makino; J-i Kuratsu; K Awai; Y Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-22       Impact factor: 3.825

Review 9.  Perfusion MRI: the five most frequently asked clinical questions.

Authors:  Marco Essig; Thanh Binh Nguyen; Mark S Shiroishi; Marc Saake; James M Provenzale; David S Enterline; Nicoletta Anzalone; Arnd Dörfler; Àlex Rovira; Max Wintermark; Meng Law
Journal:  AJR Am J Roentgenol       Date:  2013-09       Impact factor: 3.959

Review 10.  Head, neck, and brain tumor embolization guidelines.

Authors:  E Jesus Duffis; Chirag D Gandhi; Charles Joseph Prestigiacomo; Todd Abruzzo; Felipe Albuquerque; Ketan R Bulsara; Colin P Derdeyn; Justin F Fraser; Joshua A Hirsch; Muhammad Shazam Hussain; Huy M Do; Mahesh V Jayaraman; Philip M Meyers; Sandra Narayanan
Journal:  J Neurointerv Surg       Date:  2012-04-26       Impact factor: 5.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.